GGrantIndex
← Leaderboards

Michael R Verneris

Stanford University

Google Scholar ↗PubMed ↗ORCID ↗
$8,712,588
Attributed
$9,811,312
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,811,312 · 8

By mechanism

R01$6,625,354 · 3
P01$2,062,717 · 2
K08$622,205 · 1
UG1$349,037 · 1
R03$151,999 · 1

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsLeukemiaCell TherapyNatural Killer CellsImmuneProductionStem CellsEnsureProceduresTransplantationBloodPublic Health RelevanceCytokineAreaMediatingLymphocyteIn VivoHematopoietic Stem CellsCell TypeChemotherapyLaboratoriesCell ProliferationClinical TrialsBone Marrow Transplantation

Grant awards (30)

BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases$164,548
UG1 · FY2025 · HL
BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases$184,489
UG1 · FY2024 · HL
Characterizing Innate Immune Dysregulation in Tonsils of Individuals with Down Syndrome$3,038,439
R01 · FY2020 · HL · contact PI
Immune Monitoring and BiKE Production Core$122,025
P01 · FY2020 · CA · contact PI
Translational Cell Therapy Core$296,564
P01 · FY2019 · CA · contact PI
Immune Monitoring and BiKE Production Core$118,355
P01 · FY2019 · CA · contact PI
Genetic epidemiology of hematopoietic cell transplant outcomes$320,244
R01 · FY2018 · CA
Translational Cell Therapy Core$305,735
P01 · FY2018 · CA · contact PI
Immune Monitoring and BiKE Production Core$127,550
P01 · FY2018 · CA · contact PI
Genetic epidemiology of hematopoietic cell transplant outcomes$366,441
R01 · FY2017 · CA
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery$357,650
R01 · FY2017 · AI · contact PI
Translational Cell Therapy Core$305,735
P01 · FY2017 · CA · contact PI
Immune Monitoring and BiKE Production Core$50,861
P01 · FY2017 · CA · contact PI
Genetic epidemiology of hematopoietic cell transplant outcomes$516,190
R01 · FY2016 · CA
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery$380,000
R01 · FY2016 · AI · contact PI
Translational Cell Therapy Core$305,735
P01 · FY2016 · CA · contact PI
Immune Monitoring and BiKE Production Core$122,278
P01 · FY2016 · CA · contact PI
Biomarkers In Pediatric Versus Adult Myelodysplastic Syndromes$75,999
R03 · FY2016 · CA · contact PI
Genetic epidemiology of hematopoietic cell transplant outcomes$529,190
R01 · FY2015 · CA · contact PI
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery$380,000
R01 · FY2015 · AI · contact PI
Translational Cell Therapy Core$307,879
P01 · FY2015 · CA · contact PI
Biomarkers in pediatric versus adult myelodysplastic syndromes$76,000
R03 · FY2015 · CA · contact PI
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery$380,000
R01 · FY2014 · AI · contact PI
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery$357,200
R01 · FY2013 · AI · contact PI
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$123,741
K08 · FY2005 · HL
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$123,741
K08 · FY2004 · HL
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$123,741
K08 · FY2003 · HL
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$92,544
K08 · FY2002 · HL
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$31,197
K08 · FY2002 · HL
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS$127,241
K08 · FY2001 · HL